Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 19Terminated 9Active not recruiting 4Withdrawn 3Unknown 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Non-small Cell Lung Cancer Harboring ROS1 Rearrangement 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × ceritinib × Clear all
NCT01964157 2019-01-11

An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement

Yonsei University

Phase 2 Unknown
32 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03399487 2019-01-11

A Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement

Yonsei University

Phase 2 Unknown
46 enrolled
Thoracic

Non-small Cell Lung Cancer Harboring ROS1 Rearrangement

Data powered by HemOnc (CC BY 4.0) Colophon âš¡